Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.

Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD. · 2013

Read Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. by Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3610294.txt.

Description

Daphne Vogel and colleagues examined the activation state of macrophages in multiple sclerosis lesions in the Journal of Neuroinflammation in 2013. Macrophages both damage tissue and support repair in MS, and their behavior depends on how they are switched on. Lab models sort them into classic inflammatory M1 cells and healing-style M2 cells. The team first calibrated markers on human macrophages grown each way, finding CD40 the clearest M1 badge and the mannose receptor the clearest M2 badge.

In brain tissue, M1 markers covered the microglia of normal-looking white matter and filled active, myelin-stripping lesions. M2 markers sat on fat-laden macrophages inside lesions and around blood vessels. Double staining settled the picture: about seventy percent of CD40-bearing macrophages in lesions also wore the M2 badge. Real lesion cells, the authors conclude, live between the textbook poles, mixing attack and repair programs in one cell.

Catalog record

CREATORVogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3610294

Browse the full library · About the Tower of Babel